Medexus Pharmaceuticals (MEDXF) Short Interest Ratio & Short Volume $1.70 +0.17 (+11.11%) (As of 11/22/2024 ET) Add Compare Share Share Short Interest Stock AnalysisChartHeadlinesShort Interest Medexus Pharmaceuticals Short Interest DataMedexus Pharmaceuticals (MEDXF) has a short interest of 76,300 shares. This marks a -16.70% decrease in short interest from the previous month. The short interest ratio (days to cover) is 11.9, indicating that it would take 11.9 days of the average trading volume of 14,997 shares to cover all short positions.Current Short Interest76,300 sharesPrevious Short Interest91,600 sharesChange Vs. Previous Month-16.70%Dollar Volume Sold Short$130,015.20Short Interest Ratio11.9 Days to CoverLast Record DateOctober 31, 2024Today's Trading Volume6,026 sharesAverage Trading Volume14,997 sharesToday's Volume Vs. Average40% Short Selling Medexus Pharmaceuticals? Sign up to receive the latest short interest report for Medexus Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartMEDXF Short Interest Over TimeMEDXF Days to Cover Over TimeMEDXF Percentage of Float Shorted Over Time Ad Colonial MetalsA “Thank You Gift” From Pres. Trump - GeniusThe "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. A tax-free gift so powerful it could reshape the financial destinies of millions of IRA and 401(k) owners…Claim your FREE 2024 Gold Guide Medexus Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 10/31/202476,300 shares $130,015.20 -16.7%N/A11.9 $1.70 10/15/202491,600 shares $171,292.00 -20.4%N/A6.6 $1.87 9/30/2024115,000 shares $224,250.00 -14.8%N/A6.8 $1.95 9/15/2024134,900 shares $269,800.00 +4.3%N/A6.4 $2.00 8/31/2024129,400 shares $235,508.00 -12.1%N/A10.7 $1.82 8/15/2024147,200 shares $262,016.00 -7.6%N/A6.5 $1.78 Get the Latest News and Ratings for MEDXF and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Medexus Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 7/31/2024159,300 shares $275,589.00 +10.1%N/A9.2 $1.73 7/15/2024144,700 shares $250,909.80 -8.2%N/A4 $1.73 6/30/2024157,600 shares $209,608.00 -3.0%N/A10 $1.33 6/15/2024162,500 shares $185,656.25 +0.8%N/A2.2 $1.14 5/31/2024161,200 shares $188,604.00 +6.5%N/A9.8 $1.17 5/15/2024151,400 shares $180,166.00 +26.9%N/A11.4 $1.19 4/30/2024119,300 shares $160,458.50 +15.2%N/A4.1 $1.35 4/15/2024103,600 shares $118,259.40 +30.5%N/A2.4 $1.14 3/31/202479,400 shares $96,788.60 +14.6%N/A3.1 $1.22 3/15/202469,300 shares $81,081.00 +56.8%N/A2.8 $1.17 2/29/202444,200 shares $58,286.54 +122.1%N/A2.1 $1.32 2/15/202419,900 shares $27,462.00 +192.7%N/A0.3 $1.38 1/15/20247,800 shares $15,522.00 +333.3%N/A0.2 $1.99 12/31/20231,800 shares $3,402.00 No ChangeN/A0.1 $1.89 11/30/20234,200 shares $4,552.80 +35.5%N/A0.4 $1.08 11/15/20233,100 shares $4,092.00 -67.4%N/A0.3 $1.32 10/31/20239,500 shares $13,965.00 -84.3%N/A0.9 $1.47 10/15/202360,300 shares $108,540.00 -92.6%N/A6.8 $1.80 9/30/2023814,300 shares $1.82 million -5.6%N/A63.6 $2.24 9/15/2023863,000 shares $2.06 million -6.7%N/A65.9 $2.39 8/31/2023925,000 shares $2.00 million +97.5%N/A24.8 $2.16 8/15/2023468,300 shares $894,453.00 -1.2%N/A8.4 $1.91 7/31/2023474,200 shares $751,607.00 -0.3%N/A46.5 $1.59 7/15/2023475,600 shares $731,472.80 +16.2%N/A23 $1.54 6/30/2023409,300 shares $568,927.00 +0.4%N/A11.2 $1.39 6/15/2023407,600 shares $362,111.84 -0.6%N/A64.7 $0.89 5/31/2023410,000 shares $378,020.00 -0.1%N/A64.1 $0.92 5/15/2023410,200 shares $370,369.58 -1.3%N/A26 $0.90 4/30/2023415,500 shares $400,001.85 +1.8%N/A62 $0.96 4/15/2023408,200 shares $449,020.00 -1.0%N/A14 $1.10 3/31/2023412,200 shares $491,466.06 -0.9%N/A19.8 $1.19 3/15/2023415,800 shares $469,854.00 +2.0%N/A80 $1.13 2/28/2023407,600 shares $538,032.00 0.0%N/A10.1 $1.32 2/15/2023407,700 shares $387,315.00 +0.0%N/A14.2 $0.95Ever heard of this 8-day bitcoin profit window? (Ad)Did you know Bitcoin almost always soars higher during an 8-Day Profit Window? Most people have no clue… But for over a year now, some of our top students have had the chance to cash in with some incredible gains during this 8-day window.It’s coming up quick. 1/31/2023407,600 shares $574,716.00 -0.5%N/A10.3 $1.41 1/15/2023409,800 shares $649,533.00 +4.4%N/A9.9 $1.59 12/30/2022392,600 shares $604,604.00 -1.3%N/A14.5 $1.54 12/15/2022397,700 shares $562,586.42 +0.1%N/A12.5 $1.41 11/30/2022397,500 shares $680,758.50 +11.2%N/A19.1 $1.71 11/15/2022357,500 shares $493,350.00 +0.3%N/A9.3 $1.38 10/31/2022356,300 shares $381,241.00 +2.6%N/A15.6 $1.07 10/15/2022347,300 shares $309,097.00 +37.3%N/A7.1 $0.89 9/30/2022253,000 shares $179,655.30 +41.7%N/A2.3 $0.71 9/15/2022178,500 shares $255,255.00 -4.6%N/A12.4 $1.43 8/31/2022187,100 shares $357,361.00 +298.1%N/A8.5 $1.91 8/15/202247,000 shares $114,680.00 -23.1%N/A1.8 $2.44 7/31/202261,100 shares $109,980.00 -17.4%N/A5.4 $1.80 7/15/202274,000 shares $101,594.60 -15.7%N/A9.6 $1.37 6/30/202287,800 shares $135,212.00 -3.4%N/A9.4 $1.54 6/15/202290,900 shares $136,386.36 -16.6%N/A23.3 $1.50 5/31/2022109,000 shares $182,030.00 +6.2%N/A4.7 $1.67 5/15/2022102,600 shares $218,025.00 -2.1%N/A13.5 $2.13 4/30/2022104,800 shares $247,852.00 -0.9%N/A36.1 $2.37 4/15/2022105,700 shares $270,592.00 -2.3%N/A13.2 $2.56 3/31/2022108,200 shares $271,582.00 -8.0%N/A12 $2.51 3/15/2022117,600 shares $277,100.88 -11.0%N/A13.1 $2.36 2/28/2022132,100 shares $344,781.00 -3.4%N/A6.6 $2.61 2/15/2022136,700 shares $358,154.00 -7.5%N/A8.5 $2.62 1/31/2022147,700 shares $336,756.00 +0.5%N/A6.2 $2.28 1/15/2022147,000 shares $313,110.00 +6.6%N/A7.4 $2.13 12/31/2021137,900 shares $277,179.00 -4.2%N/A3.5 $2.01 12/15/2021143,900 shares $274,849.00 +38.6%N/A3.1 $1.91 11/30/2021103,800 shares $223,170.00 +84.0%N/A2.4 $2.15 11/15/202156,400 shares $133,386.00 +35.6%N/A1.5 $2.37 10/29/202141,600 shares $110,240.00 +112.2%N/A1.7 $2.65 10/15/202119,600 shares $55,693.40 +78.2%N/A0.7 $2.84 9/30/202111,000 shares $26,015.00 No ChangeN/A0.5 $2.37 8/31/20215,700 shares $18,810.00 +90.0%N/A0.1 $3.30 8/13/20213,000 shares $9,600.00 +500.0%N/A0 $3.20 7/30/2021500 shares $2,942.50 -54.6%N/A0 $5.89 7/15/20211,100 shares $6,644.00 +175.0%N/A0 $6.04 6/30/2021400 shares $2,368.00 -75.0%N/A0 $5.92 6/15/20211,600 shares $10,568.16 +100.0%N/A0 $6.61 5/28/2021800 shares $4,848.00 -11.1%N/A0 $6.06 5/14/2021900 shares $5,178.60 -52.6%N/A0 $5.75 4/30/20211,900 shares $11,685.00 +171.4%N/A0 $6.15 4/15/2021700 shares $4,102.70 -12.5%N/A0 $5.86 3/31/2021800 shares $5,058.56 -66.7%N/A0 $6.32 3/15/20212,400 shares $13,920.00 -96.8%N/A0 $5.80 2/26/202175,300 shares $463,848.00 -1.4%N/A1.5 $6.16 2/12/202176,400 shares $0.00 +159.9%N/A3 $0.00 1/29/202129,400 shares $0.00 +988.9%N/A0.5 $0.00 1/15/20216,300 shares $0.00 +530.0%N/A0.3 $0.00 12/31/20203,300 shares $0.00 -47.6%N/A0.3 $0.00Ever heard of this 8-day bitcoin profit window? (Ad)Did you know Bitcoin almost always soars higher during an 8-Day Profit Window? Most people have no clue… But for over a year now, some of our top students have had the chance to cash in with some incredible gains during this 8-day window.It’s coming up quick. MEDXF Short Interest - Frequently Asked Questions What is Medexus Pharmaceuticals' current short interest? Short interest is the volume of Medexus Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of October 31st, traders have sold 76,300 shares of MEDXF short. Learn More on Medexus Pharmaceuticals' current short interest. What is a good short interest ratio for Medexus Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. MEDXF shares currently have a short interest ratio of 12.0. Learn More on Medexus Pharmaceuticals's short interest ratio. Is Medexus Pharmaceuticals' short interest increasing or decreasing? Medexus Pharmaceuticals saw a decline in short interest during the month of October. As of October 31st, there was short interest totaling 76,300 shares, a decline of 16.7% from the previous total of 91,600 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.08 billion), AppLovin Co. ($3.18 billion), Paychex, Inc. ($2.64 billion), Nu Holdings Ltd. ($2.54 billion), International Paper ($2.46 billion), Cencora, Inc. ($2.27 billion), Moderna, Inc. ($1.87 billion), SoFi Technologies, Inc. ($1.81 billion), Lululemon Athletica Inc. ($1.75 billion), and Onsemi ($1.71 billion). View all of the most shorted stocks. What does it mean to sell short Medexus Pharmaceuticals stock? Short selling MEDXF is an investing strategy that aims to generate trading profit from Medexus Pharmaceuticals as its price is falling. MEDXF shares are trading up $0.17 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Medexus Pharmaceuticals? A short squeeze for Medexus Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of MEDXF, which in turn drives the price of the stock up even further. How often is Medexus Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including MEDXF, twice per month. The most recent reporting period available is October, 31 2024. More Short Interest Resources from MarketBeat Related Companies TGIFF Short Squeeze CATV Short Squeeze FFNTF Short Squeeze ABSCF Short Squeeze ACRHF Short Squeeze ACRDF Short Squeeze ALEAF Short Squeeze LBTSF Short Squeeze ALVOW Short Squeeze ERBB Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:MEDXF) was last updated on 11/23/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredNvidia’s world of pain awaitsThe Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredBut another coin could soar even higher …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Medexus Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Medexus Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
